Peijuan Lu

1.2k total citations
34 papers, 1.0k citations indexed

About

Peijuan Lu is a scholar working on Molecular Biology, Biomaterials and Genetics. According to data from OpenAlex, Peijuan Lu has authored 34 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 8 papers in Biomaterials and 8 papers in Genetics. Recurrent topics in Peijuan Lu's work include Muscle Physiology and Disorders (19 papers), RNA Interference and Gene Delivery (17 papers) and Advanced biosensing and bioanalysis techniques (8 papers). Peijuan Lu is often cited by papers focused on Muscle Physiology and Disorders (19 papers), RNA Interference and Gene Delivery (17 papers) and Advanced biosensing and bioanalysis techniques (8 papers). Peijuan Lu collaborates with scholars based in United States, United Kingdom and Sweden. Peijuan Lu's co-authors include Bo Wu, Qi Long Lu, Qilong Lu, Timothy J. Doran, Mingxing Wang, Caryn Cloer, Sapana N. Shah, Xiao Xiao, Hong M. Moulton and Yongfu Li and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and PLoS ONE.

In The Last Decade

Peijuan Lu

33 papers receiving 989 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peijuan Lu United States 18 889 207 119 116 105 34 1.0k
Caroline Godfrey United Kingdom 16 1.5k 1.7× 192 0.9× 209 1.8× 73 0.6× 68 0.6× 24 1.6k
Bruno M.D.C. Godinho United States 20 1.3k 1.4× 113 0.5× 47 0.4× 156 1.3× 110 1.0× 30 1.6k
Jonathan Yen United States 13 950 1.1× 219 1.1× 96 0.8× 72 0.6× 156 1.5× 28 1.1k
Aude Robert France 15 706 0.8× 207 1.0× 40 0.3× 52 0.4× 48 0.5× 34 945
Jason G. Fewell United States 18 704 0.8× 200 1.0× 25 0.2× 56 0.5× 126 1.2× 30 1.1k
Caryn Cloer United States 12 554 0.6× 162 0.8× 74 0.6× 51 0.4× 48 0.5× 13 1.2k
Erin E Vaughan United States 12 407 0.5× 136 0.7× 135 1.1× 104 0.9× 81 0.8× 18 731
Thibault Coursindel France 10 639 0.7× 91 0.4× 88 0.7× 32 0.3× 39 0.4× 16 691
Benjamin D. Pope United States 15 558 0.6× 112 0.5× 29 0.2× 70 0.6× 126 1.2× 18 856
Carmen Bertoni United States 17 662 0.7× 246 1.2× 74 0.6× 32 0.3× 17 0.2× 27 763

Countries citing papers authored by Peijuan Lu

Since Specialization
Citations

This map shows the geographic impact of Peijuan Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peijuan Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peijuan Lu more than expected).

Fields of papers citing papers by Peijuan Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peijuan Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peijuan Lu. The network helps show where Peijuan Lu may publish in the future.

Co-authorship network of co-authors of Peijuan Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Peijuan Lu. A scholar is included among the top collaborators of Peijuan Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peijuan Lu. Peijuan Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Mingxing, et al.. (2020). Triazine-cored polymeric vectors for antisense oligonucleotide delivery in vitro and in vivo. Journal of Nanobiotechnology. 18(1). 34–34. 4 indexed citations
2.
Wang, Mingxing, Bo Wu, Sapana N. Shah, Peijuan Lu, & Qilong Lu. (2019). Aminoglycoside Enhances the Delivery of Antisense Morpholino Oligonucleotides In Vitro and in mdx Mice. Molecular Therapy — Nucleic Acids. 16. 663–674. 9 indexed citations
3.
Cataldi, Marcela P., et al.. (2019). ISPD Overexpression Enhances Ribitol-Induced Glycosylation of α-Dystroglycan in Dystrophic FKRP Mutant Mice. Molecular Therapy — Methods & Clinical Development. 17. 271–280. 17 indexed citations
4.
Wang, Mingxing, Bo Wu, Sapana N. Shah, Peijuan Lu, & Qilong Lu. (2018). Saponins enhance exon skipping of 2′-O-methyl phosphorothioate oligonucleotide in vitro and in vivo. Drug Design Development and Therapy. Volume 12. 3705–3715. 6 indexed citations
5.
Wang, Mingxing, Bo Wu, Sapana N. Shah, Peijuan Lu, & Qilong Lu. (2018). Saponins as Natural Adjuvant for Antisense Morpholino Oligonucleotides Delivery In Vitro and in mdx Mice. Molecular Therapy — Nucleic Acids. 11. 192–202. 14 indexed citations
6.
Wu, Bo, Sapana N. Shah, Peijuan Lu, et al.. (2018). Long-Term Treatment of Tamoxifen and Raloxifene Alleviates Dystrophic Phenotype and Enhances Muscle Functions of FKRP Dystroglycanopathy. American Journal Of Pathology. 188(4). 1069–1080. 27 indexed citations
7.
Vannoy, Charles H., Will Xiao, Peijuan Lu, Xiao Xiao, & Qi Long Lu. (2017). Efficacy of Gene Therapy Is Dependent on Disease Progression in Dystrophic Mice with Mutations in the FKRP Gene. Molecular Therapy — Methods & Clinical Development. 5. 31–42. 27 indexed citations
8.
Wang, Mingxing, et al.. (2017). Tween 85-Modified Low Molecular Weight PEI Enhances Exon-Skipping of Antisense Morpholino Oligomer In Vitro and in mdx Mice. Molecular Therapy — Nucleic Acids. 9. 120–131. 3 indexed citations
9.
10.
Wang, Mingxing, et al.. (2016). Poly(ester amine) Composed of Polyethylenimine and Pluronic Enhance Delivery of Antisense Oligonucleotides In Vitro and in Dystrophic mdx Mice. Molecular Therapy — Nucleic Acids. 5(8). e341–e341. 7 indexed citations
11.
Wang, Mingxing, et al.. (2015). Cationic polyelectrolyte-mediated delivery of antisense morpholino oligonucleotides for exon-skipping in vitro and in mdx mice. International Journal of Nanomedicine. 10. 5635–5635. 12 indexed citations
12.
Wu, Bo, Caryn Cloer, Peijuan Lu, et al.. (2014). Exon skipping restores dystrophin expression, but fails to prevent disease progression in later stage dystrophic dko mice. Gene Therapy. 21(9). 785–793. 35 indexed citations
13.
14.
Wu, Bo, Peijuan Lu, Caryn Cloer, et al.. (2012). Long-Term Rescue of Dystrophin Expression and Improvement in Muscle Pathology and Function in Dystrophic mdx Mice by Peptide-Conjugated Morpholino. American Journal Of Pathology. 181(2). 392–400. 62 indexed citations
15.
Wang, Mingxing, et al.. (2012). Polyethylenimine-modified Pluronics (PCMs) Improve Morpholino Oligomer Delivery in Cell Culture and Dystrophic mdx Mice. Molecular Therapy. 21(1). 210–216. 30 indexed citations
16.
Wang, Chi‐Hsien, Yiu-mo Chan, Ruhang Tang, et al.. (2011). Post-Natal Knockdown of Fukutin-Related Protein Expression in Muscle by Long-Term RNA Interference Induces Dystrophic Pathology. American Journal Of Pathology. 178(1). 261–272. 11 indexed citations
17.
Wu, Bo, et al.. (2011). Targeted Skipping of Human Dystrophin Exons in Transgenic Mouse Model Systemically for Antisense Drug Development. PLoS ONE. 6(5). e19906–e19906. 15 indexed citations
18.
Wu, Bo, Bin Xiao, Caryn Cloer, et al.. (2010). One-year Treatment of Morpholino Antisense Oligomer Improves Skeletal and Cardiac Muscle Functions in Dystrophic mdx Mice. Molecular Therapy. 19(3). 576–583. 54 indexed citations
19.
Hu, Yihong, Bo Wu, Peijuan Lu, et al.. (2010). Guanine Analogues Enhance Antisense Oligonucleotide-induced Exon Skipping in Dystrophin Gene In Vitro and In Vivo. Molecular Therapy. 18(4). 812–818. 28 indexed citations
20.
Baeckström, Dan, Peijuan Lu, & Joyce Taylor‐Papadimitriou. (2000). Activation of the α2β1 integrin prevents c-erbB2-induced scattering and apoptosis of human mammary epithelial cells in collagen. Oncogene. 19(40). 4592–4603. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Caroline Godfrey Breakdown of academic impact, for papers by Bruno M.D.C. Godinho Breakdown of academic impact, for papers by Jonathan Yen Breakdown of academic impact, for papers by Aude Robert Breakdown of academic impact, for papers by Jason G. Fewell Breakdown of academic impact, for papers by Caryn Cloer Breakdown of academic impact, for papers by Erin E Vaughan Breakdown of academic impact, for papers by Thibault Coursindel Breakdown of academic impact, for papers by Benjamin D. Pope Breakdown of academic impact, for papers by Carmen Bertoni
Rankless by CCL
2026